In 2024, Indianapolis recorded 209 homicides showing another decrease from years prior.
It was the third straight year the city saw a decrease, but was the fifth year in a row that police have investigated more than 200 homicides.
Here's a look at the 2025 homicide data for Marion County.
IMPD’s Chief of Police Chris Bailey says the reduction in homicides is due to several factors, including the Crime Guns Task Force, license plate readers and dash cameras.
"We saw in this city one of the biggest reductions in criminal homicides over a three-year period than any other major city," Bailey said.
He also says his priorities for 2025 include reducing violent crime, enhancing relationships within the community, focusing on retention, and hiring new officers.
Chief Bailey says although he is proud of the progress made in reducing violent crime, more work needs to be done.
"There are many families and communities that have been impacted by violent crime this year, specifically murder, and we have to recognize those victims," Bailey said. "They're not numbers, and even though the number may go back to zero on January 1, that is not a number to a family or a community. They are a person, and they're gone."
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.